Lung

, Volume 186, Issue 5, pp 307–312 | Cite as

Patterns of Healthcare Utilization by COPD Severity: A Pilot Study

  • Min J. Joo
  • Todd A. Lee
  • Brian Bartle
  • William B. van de Graaff
  • Kevin B. Weiss
Article

Abstract

Global Initiative on Chronic Obstructive Lung Disease (GOLD) guidelines recently removed stage 0, a group with symptoms but without airways obstruction, from their severity staging. However, in practice this group may still be diagnosed and medically managed. The aim of this study was to characterize healthcare utilization patterns of chronic obstructive pulmonary disease (COPD) patients by disease severity, focusing on the possible unique attributes of patients who would have been classified as GOLD stage 0. This is a prospective cohort pilot study performed at the Hines Veterans Administration Hospital. One hundred twenty patients with a diagnosis of COPD were enrolled. The participants completed quality-of-life questionnaires and a pulmonary function test. Healthcare utilization data were obtained 1 year prior and 2 years after the enrollment date. Three disease severity groups were defined based on GOLD criteria for comparison [GOLD stage 1–2 (GS 1–2), GOLD stage 3–4 (GS 3–4), and formerly GOLD stage 0 (“at risk”)]. The “at risk” group had an average of 14.4 (SD = 30.5) outpatient visits/year and 0.3 (SD = 0.8) hospitalizations/year, which were higher than the other groups, but this was not statistically significant. Respiratory medications were used by 6 (26%), 30 (59%), and 40 (91%) patients from “at risk” to GS 3–4, respectively. Patients in the “at risk” group had a decrement in health status, significant utilization of healthcare services, and were often receiving medications not consistent with guidelines.

Keywords

Chronic obstructive pulmonary disease Health status Healthcare Health services research 

References

  1. 1.
    Morbidity & Mortality (2007) Chart book on cardiovascular, lung, and blood diseases. National Institutes of Health, National Heart, Lung, and Blood Institute, Bethesda, MDGoogle Scholar
  2. 2.
    Global Inititiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease (updated 2006). http://www.goldcopd.org/Guidelineitem.asp?l1=2&l2=1&intId=989. Accessed 1 December 2007
  3. 3.
    Han MK, Kim MG, Mardon R, Renner P, Sullivan S, Diette GB, Martinez FJ (2007) Spirometry utilization for COPD: how do we measure up? Chest 132:403–409PubMedCrossRefGoogle Scholar
  4. 4.
    Lee TA, Bartle B, Weiss KB (2006) Spirometry use in clinical practice following diagnosis of COPD. Chest 129:1509–1515PubMedCrossRefGoogle Scholar
  5. 5.
    Agency for Healthcare Research and Quality (2005) Use of spirometry for case finding, diagnosis and management of chronic obstructive pulmonary disease (COPD). www.ohrq.gov/downloads/pud/evidence/pdf/spirocopd/spiro.pdf. Accessed 1 December 2007
  6. 6.
    Mannino DM, Gagnon RC, Petty TL, Lydick E (2000) Obstructive lung disease and low lung function in adults in the United States: data from the National Health and Nutrition Examination Survey, 1988–1994. Arch Intern Med 160:1683–1689PubMedCrossRefGoogle Scholar
  7. 7.
    Antonelli-Incalzi R, Imperiale C, Bellia V, Catalano F, Scichilone N, Pistelli R, Rengo F (2003) Do GOLD stages of COPD severity really correspond to differences in health status? Eur Respir J 22:444–449PubMedCrossRefGoogle Scholar
  8. 8.
    Enright PL, Crapo RO (2000) Controversies in the use of spirometry for early recognition and diagnosis of chronic obstructive pulmonary disease in cigarette smokers. Clin Chest Med 21:645–652PubMedCrossRefGoogle Scholar
  9. 9.
    Lindberg A, Eriksson B, Larsson LG, Ronmark E, Sandstrom T, Lundback B (2006) Seven-year cumulative incidence of COPD in an age-stratified general population sample. Chest 129:879–885PubMedCrossRefGoogle Scholar
  10. 10.
    Lindberg A, Jonsson AC, Ronmark E, Lundgren R, Larsson LG, Lundback B (2005) Ten-year cumulative incidence of COPD and risk factors for incident disease in a symptomatic cohort. Chest 127:1544–1552PubMedCrossRefGoogle Scholar
  11. 11.
    Vestbo J, Lange P (2002) Can GOLD Stage 0 provide information of prognostic value in chronic obstructive pulmonary disease? Am J Respir Crit Care Med 166:329–332PubMedCrossRefGoogle Scholar
  12. 12.
    Ekberg-Aronsson M, Pehrsson K, Nilsson JA, Nilsson PM, Lofdahl CG (2005) Mortality in GOLD stages of COPD and its dependence on symptoms of chronic bronchitis. Respir Res 6:98PubMedCrossRefGoogle Scholar
  13. 13.
    Ferrer M, Alonso J, Morera J, Marrades RM, Khalaf A, Aguar MC, Plaza V, Prieto L, Anto JM (1997) Chronic obstructive pulmonary disease stage and health-related quality of life. The Quality of Life of Chronic Obstructive Pulmonary Disease Study Group. Ann Intern Med 127:1072–1079PubMedGoogle Scholar
  14. 14.
    Mannino DM, Doherty DE, Sonia Buist A (2006) Global Initiative on Obstructive Lung Disease (GOLD) classification of lung disease and mortality: findings from the Atherosclerosis Risk in Communities (ARIC) study. Respir Med 100:115–122PubMedCrossRefGoogle Scholar
  15. 15.
    Stavem K, Sandvik L, Erikssen J (2006) Can global initiative for Chronic Obstructive Lung Disease stage 0 provide prognostic information on long-term mortality in men? Chest 130:318–325PubMedCrossRefGoogle Scholar
  16. 16.
    Jones PW, Quirk FH, Baveystock CM (1991) The St George’s Respiratory Questionnaire. Respir Med 85 Suppl B:25–31; discussion 33–27PubMedCrossRefGoogle Scholar
  17. 17.
    Barr JT, Schumacher GE, Freeman S, LeMoine M, Bakst AW, Jones PW (2000) American translation, modification, and validation of the St. George’s Respiratory Questionnaire. Clin Ther 22:1121–1145Google Scholar
  18. 18.
    Jones PW, Quirk FH, Baveystock CM, Littlejohns P (1992) A self-complete measure of health status for chronic airflow limitation. The St. George’s Respiratory Questionnaire. Am Rev Respir Dis 145:1321–1327PubMedGoogle Scholar
  19. 19.
    Rutten-van Molken M, Roos B, Van Noord JA (1999) An empirical comparison of the St. George’s Respiratory Questionnaire (SGRQ) and the Chronic Respiratory Disease Questionnaire (CRQ) in a clinical trial setting. Thorax 54:995–1003PubMedCrossRefGoogle Scholar
  20. 20.
    Kleinbaum DG, Kupper LL, Muller KE, Nizam A (1988) Applied Regression Analysis and Other Multivariate Methods. Brooks/Cole Publishing Company, Pacific Grove, CA, pp 451–457Google Scholar
  21. 21.
    Stahl E, Lindberg A, Jansson SA, Ronmark E, Svensson K, Andersson F, Lofdahl CG, Lundback B (2005) Health-related quality of life is related to COPD disease severity. Health Qual Life Outcomes 3:56PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2008

Authors and Affiliations

  • Min J. Joo
    • 1
    • 2
    • 3
  • Todd A. Lee
    • 3
    • 4
  • Brian Bartle
    • 3
  • William B. van de Graaff
    • 5
    • 6
  • Kevin B. Weiss
    • 7
  1. 1.Section of Pulmonary, Critical Care, and Sleep Medicine, Department of MedicineUniversity of Illinois at ChicagoChicagoUSA
  2. 2.Center for the Management of Complex Chronic CareJesse Brown VA HospitalChicagoUSA
  3. 3.Center for the Management of Complex Chronic CareHines VA HospitalHinesUSA
  4. 4.Institute for Healthcare Studies, Division of General Internal Medicine, Department of MedicineNorthwestern University Feinberg School of MedicineChicagoUSA
  5. 5.Division of Pulmonary and Critical Care MedicineLoyola University Chicago Stritch School of MedicineMaywoodUSA
  6. 6.Division of Pulmonary and Critical Care MedicineHines VA HospitalHinesUSA
  7. 7.American Board of Medical SpecialtiesEvanstonUSA

Personalised recommendations